TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
UMOD | Uromodulin | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MCCD1 | Mitochondrial coiled-coil domain 1 | Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC34A1 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SLC22A6 | Solute carrier family 22 (organic anion transporter), member 6 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC7A13 | Solute carrier family 7 (anionic amino acid transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NPHS2 | Nephrosis 2, idiopathic, steroid-resistant (podocin) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MIOX | Myo-inositol oxygenase | Enzymes
| | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | | | | Tissue enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMEM207 | Transmembrane protein 207 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC5A10 | Solute carrier family 5 (sodium/sugar cotransporter), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A24 | Solute carrier family 22, member 24 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
FXYD4 | FXYD domain containing ion transport regulator 4 | Predicted membrane proteins
| | | | | Tissue enriched |
NOX4 | NADPH oxidase 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOST | Sclerostin | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
CALB1 | Calbindin 1, 28kDa | | | | | | Tissue enriched |
AC020629.1 | Uncharacterized protein | | | | | | Tissue enriched |
SLC4A9 | Solute carrier family 4, sodium bicarbonate cotransporter, member 9 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC6A13 | Solute carrier family 6 (neurotransmitter transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | | | | | | Tissue enriched |
TMEM52B | Transmembrane protein 52B | Predicted secreted proteins
| | | | | Tissue enriched |
C9orf66 | Chromosome 9 open reading frame 66 | | | | | | Tissue enriched |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | Predicted membrane proteins
| | | | | Tissue enriched |
UPP2 | Uridine phosphorylase 2 | Enzymes
| | | | | Tissue enriched |
TMEM27 | Transmembrane protein 27 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CTXN3 | Cortexin 3 | Predicted membrane proteins
| | | | | Tissue enriched |
OR2T10 | Olfactory receptor, family 2, subfamily T, member 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
C16orf11 | Chromosome 16 open reading frame 11 | | | | | | Tissue enriched |
CDH16 | Cadherin 16, KSP-cadherin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HMX2 | H6 family homeobox 2 | Transcription factors
| | | | | Tissue enriched |
LHX1 | LIM homeobox 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
PTH1R | Parathyroid hormone 1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CLCNKA | Chloride channel, voltage-sensitive Ka | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
CRYAA | Crystallin, alpha A | Disease related genes Plasma proteins
| | | | | Tissue enriched |
CRYBB3 | Crystallin, beta B3 | Disease related genes
| | | | | Tissue enriched |
CYS1 | Cystin 1 | | | | | | Tissue enriched |
FMO1 | Flavin containing monooxygenase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |